|
Chyou
PH, Nomura AM, Stemmermann GN, Hankin JH. A prospective study of
alcohol, diet and other lifestyle factors in relation to obstructive
uropathy. Prostate
1993:22;253-264.
Fair,
W. R. and Heston, W. "Prostate Inflammation Linked to Zinc
Shortage" Prevention 113: June, 1977
Dumrau F. Benign
prostatic hyperplasia: amino acid therapy for symptom relief. Am J
Geriatr 1962;10:426-430.
Menendez
Fernandez H, et al. Use of amino acids as a combination in the
treatment of prostatic hypertrophy. Arch Esp Urol 1988;
41:495-499.
Becker H,
Ebeling L. Conservative therapy of benign prostate hyperplasia (BPH)
with Cernilton®N. Results of a placebo-controlled double-blind
study [translated from German]. Urologe [B]. 1988;28:301–306.
Buck AC, Cox R,
Rees RWM, et al. Treatment of outflow tract obstruction due to benign
prostatic hyperplasia with the pollen extract, Cernilton: a
double-blind, placebo-controlled study. Br J Urol.
1990;66:398–404.
Singhal AK,
Mosbach EH, Schaffner CP. Effect of candicidin on cholesterol an bile
acid metabolism in the rat. Lipids 1981; 16:423-426.
Safarinejad MR.
Urtica dioica for treatment of benign prostatic hyperplasia: a
prospective, randomized, double-blind, placebo-controlled, crossover
study. J Herb Pharmacother. 2006;5:1-11
| 
